Form 4 Filing for Camp4 Therapeutics Corp

This filing details a transaction by Maricich Yuri, Chief Medical Officer of Camp4 Therapeutics Corp. On August 3, 2026, Yuri acquired 6,551 shares of common stock at a price of $1.65 per share. This acquisition occurred during the second closing of a private placement initiated by the company. The shares were purchased pursuant to a Securities Purchase Agreement dated September 9, 2025, as amended on August 3, 2026. This transaction brings Yuri's total post-acquisition shares to 12,611. The footnote indicates that this purchase was part of a private placement involving institutional investors, directors, employees, and consultants.